Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Graded PU.1 Levels Regulate Granulocyte Vs. Macrophage Genes Via Multiple Enhancer Elements

Vitek Pospisil, PhD, Pavle Krsmanovic, PhD, Jan Valecka, MSc, Kamila Chramostová, Vojtech Kulvait, MSc, Jiri Zavadil, PhD, Martin Vokurka, MD PhD, Peter Laslo, PhD, Tomas Stopka, MD PhD

Blood (2016) 128 (22): 403.

https://doi.org/10.1182/blood.V128.22.403.403

Published: 2016

Journal Articles

Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Is a New Biomarker for Mantle Cell Lymphoma: Expression, Localization, and Phosphorylation Study

Tomas Stopka, MD PhD, Jarmila Vargova, MSc, Karina Vargova, PhD, Nina Dusilkova, MD, Vojtech Kulvait, MSc, Vit Pospisil, PhD, Jiri Zavadil, PhD, Marek Trneny, Pavel Klener, MD PhD

Blood (2016) 128 (22): 1767.

https://doi.org/10.1182/blood.V128.22.1767.1767

Published: 2016

Journal Articles

Active Chromatin Structure near MYB Occupancy at the Mir-155 Host Gene Promoter Coincides with Increased Mir-155 and MYB Levels In Chronic Lymphocytic Leukemia

Tomas Stopka, MD, PhD, Karin Vargova, Nikola Curik, Pavel Burda, Petra Basova, Vit Pospisil, Vojtech Kulvait, Filipp Savvulidi, Emanuel Necas, MD, PhD, Adela Berkova, MD, Petra Obrtlikova, MD, Josef Karban, MD, Marek Trneny, MD, PhD, Jiri Zavadil, PhD

Blood (2010) 116 (21): 3589.

https://doi.org/10.1182/blood.V116.21.3589.3589

Published: 2010

Journal Articles

The Oncogenic Mir-17-92 MicroRNA Cluster Is Inhibited by EGR2 During Macrophage Differentiation Via JARID1b-Mediated Histone 3 Lysine 4 Demethylation

Vit Pospisil, Karin Vargova, Juraj Kokavec, Jana Rybarova, Filipp Savvulidi, Emanuel Necas, Peter Laslo, PhD, Jiri Zavadil, PhD, Tomas Stopka, MD, PhD

Blood (2010) 116 (21): 390.

https://doi.org/10.1182/blood.V116.21.390.390

Published: 2010

Journal Articles

Up-Regulation of Genes Involved in Folate Metabolism Characterize Late but Not Early Relapse in Childhood Acute Lymphoblastic Leukemia.

Laura Hogan, MD, Deepa Bhojwani, MD, Jinhua Wang, PhD, Debra Morrison, PhD, Jun J Yang, PhD, Yutong Zhang, Jiri Zavadil, PhD, Gregory Condos, Stephen P Hunger, MD, Cheryl L. Willman, MD, Mary V. Relling, PharmD, Elizabeth Raetz, MD, William L. Carroll, MD

Blood (2009) 114 (22): 1733.

https://doi.org/10.1182/blood.V114.22.1733.1733

Published: 2009

Journal Articles

DNA Damage Response Is a Barrier in the Mixed Lineage Leukemia Development.

Sylvia Takacova, PhD, Jiri Zavadil, PhD, MSC, Jiri Bartek, MD, PhD, Vladimir Divoky, PhD

Blood (2009) 114 (22): 2399.

https://doi.org/10.1182/blood.V114.22.2399.2399

Published: 2009

Journal Articles

PU.1 Relieves Its GATA-1-Mediated Repression near Cebpa and Cbfb During Transdifferentiation of Murine Erythroleukemia - Tool of Inducing Leukemic Blasts to Differentiate.

Pavel Burda, Nikola Curik, Juraj Kokavec, Dana Mikulenkova, MD, Arthur Skoultchi, PhD, Jiri Zavadil, PhD, Tomas Stopka, MD, PhD

Blood (2009) 114 (22): 547.

https://doi.org/10.1182/blood.V114.22.547.547

Published: 2009

Journal Articles

MicroRNA Mir-155 and Myb Proto-Oncogene Family Members Cooperate in Pathogenesis of Chronic Lymphocytic Leukemia.

Tomas Stopka, MD, PhD, Karin Vargova, Pavel Burda, Juraj Kokavec, Nikola Curik, Adela Berkova, MD, Marek Trneny, Arthur Skoultchi, PhD, Jiri Zavadil, PhD

Blood (2009) 114 (22): 58.

https://doi.org/10.1182/blood.V114.22.58.58

Published: 2009

Journal Articles

Classifying Leukemias Based on Epigenetic Alterations.

Jaroslav Jelinek, MD, PhD, Marcos R.H. Estecio, PhD, Kimie Kondo, MS, Rong He, MS, Jiri Zavadil, PhD, Jean-Pierre J. Issa, MD

Blood (2007) 110 (11): 2123.

https://doi.org/10.1182/blood.V110.11.2123.2123

Published: 2007

Journal Articles

Mutual Regulatory Loop between miR-155 and PU.1 Is a Candidate Pathogenesis Factor in CLL.

Tomas Stopka, MD, PhD, Karin Vargova, Msc., Juraj Kokavec, Msc., Vit Pospisil, Msc., Nikola Curik, Msc., Pavel Burda, Msc., Arthur I. Skoultchi, PhD., Jiri Zavadil, PhD.

Blood (2007) 110 (11): 1130.

https://doi.org/10.1182/blood.V110.11.1130.1130

Published: 2007

Journal Articles

Fog1 and Cebpa Are DNA Targets of GATA-1/PU.1 Antagonism during Leukemia Differentiation.

Pavel Burda, Msc., Nikola Curik, Msc., Juraj Kokavec, Msc., Vit Pospisil, Msc., Arthur I. Skoultchi, PhD., Jiri Zavadil, PhD., Tomas Stopka, MD, PhD

Blood (2007) 110 (11): 4121.

https://doi.org/10.1182/blood.V110.11.4121.4121

Published: 2007

Journal Articles

PU.1 Dose-Dependently Induces Granulocyte or Macrophage Commitment by Targeting Lineage Restricted Genes and by Regulating Transcription Factors Egr2, Nab2, Cebpa and Gfi1.

Vit Pospisil, Msc., Juraj Kokavec, Msc., Pavel Burda, Msc., Nikola Curik, Msc., Arthur I. Skoultchi, PhD., Jiri Zavadil, PhD., Tomas Stopka, MD, PhD

Blood (2007) 110 (11): 661.

https://doi.org/10.1182/blood.V110.11.661.661

Published: 2007

NARROW

Graded PU.1 Levels Regulate Granulocyte Vs. Macrophage Genes Via Multiple Enhancer Elements

Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Is a New Biomarker for Mantle Cell Lymphoma: Expression, Localization, and Phosphorylation Study

Active Chromatin Structure near MYB Occupancy at the Mir-155 Host Gene Promoter Coincides with Increased Mir-155 and MYB Levels In Chronic Lymphocytic Leukemia

The Oncogenic Mir-17-92 MicroRNA Cluster Is Inhibited by EGR2 During Macrophage Differentiation Via JARID1b-Mediated Histone 3 Lysine 4 Demethylation

Up-Regulation of Genes Involved in Folate Metabolism Characterize Late but Not Early Relapse in Childhood Acute Lymphoblastic Leukemia.

DNA Damage Response Is a Barrier in the Mixed Lineage Leukemia Development.

PU.1 Relieves Its GATA-1-Mediated Repression near Cebpa and Cbfb During Transdifferentiation of Murine Erythroleukemia - Tool of Inducing Leukemic Blasts to Differentiate.

MicroRNA Mir-155 and Myb Proto-Oncogene Family Members Cooperate in Pathogenesis of Chronic Lymphocytic Leukemia.

Classifying Leukemias Based on Epigenetic Alterations.

Mutual Regulatory Loop between miR-155 and PU.1 Is a Candidate Pathogenesis Factor in CLL.

Fog1 and Cebpa Are DNA Targets of GATA-1/PU.1 Antagonism during Leukemia Differentiation.

PU.1 Dose-Dependently Induces Granulocyte or Macrophage Commitment by Targeting Lineage Restricted Genes and by Regulating Transcription Factors Egr2, Nab2, Cebpa and Gfi1.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only